Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Biotech Marks Time. More details...
CBT 200 Loses Calamitous 4.26%. More details...
What Are the Company's Prospects Following Recall?. More...
Oil Price Spike Spooks Investors. More details...
Wonder Drug Casts Pall Over Sector. More details...
CBT 200 Follows Market Lower. More details...
Biotech Gets a Boost From Good Clinical News. More...
Pfizer News Gives Sector a Positive Spin. More details...
Drug Also in MS Trials. More details...
Biotech and Pfizer Overlook Negative News. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
